What is the current Children Influenza Vaccine market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Children Influenza Vaccine market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Children Influenza Vaccine market?

Increasing awareness and government initiatives are driving the market.

What are the major challenges facing the Children Influenza Vaccine market?

Vaccine hesitancy and limited access to healthcare are significant challenges.

Which regions are leading the Children Influenza Vaccine market?

North America and Europe are the leading regions in the market.

Who are the top companies in the Children Influenza Vaccine market?

Pfizer, GlaxoSmithKline, and Sanofi are among the top companies.

What are the future opportunities in the Children Influenza Vaccine market?

Emerging markets and innovative vaccine technologies offer future opportunities.

How is technology impacting the Children Influenza Vaccine market?

Advances in vaccine development and digital healthcare are transforming the market.

What is the current regulatory landscape for the Children Influenza Vaccine market?

Regulatory bodies are implementing policies to ensure vaccine safety and efficacy.

What is the future outlook for the Children Influenza Vaccine market size?

The market is expected to reach USD 2.5 billion by 2033.

Children Influenza Vaccine Growth Drivers & Forecast Analysis 2033

Children Influenza Vaccine by Application (Public, Private), by Types (Nasal Spray, Injection), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Children Influenza Vaccine Market Overview

The Children Influenza Vaccine market is a critical segment of the global healthcare industry, playing a vital role in preventing and controlling influenza outbreaks among children. As the Children Influenza Vaccine market size is expected to reach $4.5 billion by 2026, the growth outlook and market forecast until 2033 indicate a promising industry expansion, driven by increasing awareness about the importance of vaccination and government initiatives to improve vaccine coverage. The scope of this market encompasses various types of vaccines, including trivalent and quadrivalent vaccines, and their applications in different regions.

Loading chart…

The Children Influenza Vaccine market is expected to grow at a CAGR of 7.5% from 2026 to 2033, driven by macro drivers such as increasing demand for vaccines, advancements in vaccine technology, and government support for vaccination programs. Key forces shaping the industry include technology shifts towards more effective and convenient vaccine formulations, regulations and standards for vaccine safety and efficacy, and consumer behavior driven by awareness and education. The largest region for the Children Influenza Vaccine market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing healthcare expenditure and government initiatives to improve vaccine coverage.

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	24.05 million
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sanofi; CSL; GSK; Viatris; Hulan Bio; AstraZeneca; CCBIO; Sinovac; BCHT; Jiangsu GDK; KM Biologics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Children Influenza Vaccine market is poised for significant growth, driven by increasing awareness of the importance of vaccination and government initiatives to improve vaccination rates. The Children Influenza Vaccine market size is expected to expand substantially over the forecast period, with a growth forecast that indicates a promising future for vaccine manufacturers.

Growth Drivers2 items

Advances in vaccine technology, such as the development of quadrivalent vaccines, are driving growth in the Children Influenza Vaccine market by providing broader protection against multiple influenza strains.

Government initiatives and recommendations from health organizations, such as the Centers for Disease Control and Prevention (CDC), are increasing demand for children influenza vaccines, contributing to the growth of the Children Influenza Vaccine market size.

Restraints2 items

Vaccine hesitancy and misinformation about vaccine safety and efficacy are significant restraints on the growth of the Children Influenza Vaccine market, as they can lead to reduced vaccination rates.

Supply chain disruptions and manufacturing capacity constraints can limit the availability of children influenza vaccines, hindering the growth forecast of the Children Influenza Vaccine market.

Opportunities2 items

The development of new vaccine formulations, such as needle-free vaccines, presents opportunities for growth in the Children Influenza Vaccine market by improving vaccination experiences and increasing demand.

Expanding vaccination programs in emerging markets and low-income countries offers significant opportunities for growth in the Children Influenza Vaccine market size, driven by increasing access to healthcare services.

Challenges2 items

Managing the complexities of vaccine distribution and storage, particularly in resource-constrained settings, is a significant challenge facing the Children Influenza Vaccine market, requiring innovative solutions to maintain vaccine potency.

Addressing the ongoing issue of antimicrobial resistance and ensuring the long-term efficacy of children influenza vaccines are critical challenges that must be addressed to sustain the growth forecast of the Children Influenza Vaccine market.

Market Segmentation

Loading chart…

The Application segment of the Children Influenza Vaccine market refers to the different areas where these vaccines are utilized. This includes hospitals, clinics, and community health centers. Understanding the application segment is crucial as it helps in identifying the target audience and tailoring marketing strategies accordingly. The Children Influenza Vaccine segmentation by application contributes significantly to the overall market size, with each application area having its own set of requirements and preferences.

The Types segment of the Children Influenza Vaccine market is further divided into subtypes, including trivalent and quadrivalent vaccines. Each subtype has its own set of characteristics, advantages, and target populations. For instance, trivalent vaccines protect against three different flu viruses, while quadrivalent vaccines protect against four. Analyzing the types segment is essential for understanding the Children Influenza Vaccine segmentation and developing effective market strategies. This segment plays a vital role in determining the market size, as different types of vaccines are preferred in various regions and demographics.

Children Influenza Vaccine Segmentation Breakdown6 items

Application

Public

Private

Types

Nasal Spray

Injection

Regional Insights

Loading chart…

The Children Influenza Vaccine market is poised for significant growth, driven by increasing awareness and adoption of preventive measures against influenza. The largest region in the Children Influenza Vaccine market is Asia Pacific, accounting for approximately 40% of the global market share, driven by key drivers such as large population demographics, government investments in healthcare infrastructure, and rising ecosystem maturity. The fastest-growing region is Latin America, with a growth rate driven by expanding healthcare access, favorable government policies, and growing awareness about the importance of vaccinations.

In North America, key drivers include high adoption rates of influenza vaccines, well-established healthcare infrastructure, and significant investments in research and development. Europe is driven by factors such as strong ecosystem maturity, favorable regulatory policies, and high healthcare expenditure. Asia Pacific is driven by large population demographics, government investments in healthcare infrastructure, and rising ecosystem maturity. Latin America is driven by expanding healthcare access, favorable government policies, and growing awareness about the importance of vaccinations. Middle East & Africa is driven by increasing healthcare expenditure, government initiatives to improve healthcare infrastructure, and growing demand for preventive measures against influenza.

The regional forecast indicates a positive outlook for the Children Influenza Vaccine market growth, with each region presenting unique opportunities and challenges. Understanding these regional dynamics is crucial for stakeholders to develop effective strategies and capitalize on emerging trends in the Children Influenza Vaccine market.

Competitive Landscape

The Children Influenza Vaccine market is moderately consolidated, driven by a mix of global players and local/regional companies. The Children Influenza Vaccine competitive landscape is shaped by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and regulatory approvals, while local companies emphasize distribution and pricing strategies.

Companies employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages.

Sanofi: regional expansion

CSL: premium pricing

GSK: innovation pipeline

Viatris: OEM tie-ups

Hulan Bio: local manufacturing

AstraZeneca: vertical integration

Key Children Influenza Vaccine Companies11 items

Sanofi

CSL

GSK

Viatris

Hulan Bio

AstraZeneca

CCBIO

Sinovac

BCHT

Jiangsu GDK

KM Biologics

Market Ecosystem

The Children Influenza Vaccine ecosystem encompasses a complex network of stakeholders, spanning from upstream technology providers and suppliers to downstream end users, including various intermediaries such as integrators, channels, and service providers. This ecosystem is characterized by the creation and capture of value through the development, manufacturing, and distribution of vaccines, as well as the provision of related services. The boundaries of this ecosystem are defined by the interactions and interdependencies among these stakeholders, influencing the overall efficiency and effectiveness of the value chain.

Raw material suppliers — providing vaccine components

OEMs / manufacturers — producing influenza vaccines

Technology providers — developing vaccine technologies

Distributors / channel partners — delivering vaccines to healthcare providers

Service providers / after-sales — offering vaccination services and support

Regulators/standards bodies — overseeing vaccine safety and efficacy

End users / buyers — receiving and administering influenza vaccines

In the Children Influenza Vaccine ecosystem, control points are primarily held by regulators and standards bodies, as they influence adoption through safety and efficacy approvals. Dependency risks arise from input constraints, such as limited supply of certain vaccine components, and standards, which can vary by region. Switching costs and partnerships are also critical, as they impact the ability of stakeholders to adapt to changing market conditions. Furthermore, the ecosystem differs by region due to diverse regulatory requirements, healthcare infrastructure, and vaccination strategies, highlighting the need for a value chain analysis to navigate these complexities.

Recent Industry Insights

The Children Influenza Vaccine industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships have been formed between key players to enhance vaccine development and distribution. Mergers and acquisitions have also been observed, with companies like Sanofi and GSK expanding their portfolios. Furthermore, innovative product launches, such as quadrivalent flu vaccines, have improved the industry's landscape. Regulatory changes, including the FDA's approval of flu vaccines for younger age groups, have also contributed to the growth of the market. Additionally, there has been a shift in consumer trends, with an increased focus on preventative care, driving demand for Children Influenza Vaccines. Recent funding rounds have also been secured by companies to support research and development of new vaccines, further propelling the industry forward.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Children Influenza Vaccine market. The market attractiveness is moderate, driven by increasing awareness of vaccination benefits and government initiatives. The competitive intensity is high, with multiple players competing for market share. The long-term outlook for the Children Influenza Vaccine market outlook is positive, with growing demand for vaccines in developing countries. However, the innovation landscape is relatively stagnant, with few new vaccine developments in recent years. The demand-supply balance is stable, with manufacturers meeting current demand. Key risk factors include vaccine shortages, supply chain disruptions, and fluctuating government policies.

12 items

1. Executive Summary

2. Children Influenza Vaccine Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Children Influenza Vaccine Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Children Influenza Vaccine Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Children Influenza Vaccine Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Children Influenza Vaccine Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Children Influenza Vaccine Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Children Influenza Vaccine Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Children Influenza Vaccine Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Children Influenza Vaccine Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Children Influenza Vaccine Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Children Influenza Vaccine Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Children Influenza Vaccine Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Children Influenza Vaccine Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Children Influenza Vaccine Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Children Influenza Vaccine Market Competition by Key Manufacturers

9.1. Global Children Influenza Vaccine Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Children Influenza Vaccine: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Sanofi

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. CSL

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. GSK

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Viatris

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Hulan Bio

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. AstraZeneca

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. CCBIO

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Sinovac

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. BCHT

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Jiangsu GDK

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. KM Biologics

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Children Influenza Vaccine Market

Figure 4: Global Children Influenza Vaccine Market: Drivers

Figure 5: Global Children Influenza Vaccine Market: Challenges

Figure 6: Global Children Influenza Vaccine Market: Trends

Figure 7: Global Children Influenza Vaccine Market: Opportunity

Figure 8: Global Children Influenza Vaccine Market: Restraint

Figure 9: Global Children Influenza Vaccine Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Children Influenza Vaccine Market Value (USD Million) By Region

Figure 19: Global Children Influenza Vaccine Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Children Influenza Vaccine Market Value (USD Million) By Region

Figure 27: Global Children Influenza Vaccine Market Share (%) By: Regions (2032)

Figure 28: Global Children Influenza Vaccine Market Volume (K) By Region

Figure 29: Global Children Influenza Vaccine Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Children Influenza Vaccine Market Value (USD Million) By Region

Figure 37: Global Children Influenza Vaccine Market Share (%) By: Regions (2032)

Figure 38: Global Children Influenza Vaccine Market Volume (K) By Region

Figure 39: Global Children Influenza Vaccine Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

117 items

Table 1: Market Segmentation Analysis

Table 2: Global Children Influenza Vaccine Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Children Influenza Vaccine Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Children Influenza Vaccine Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Children Influenza Vaccine Market Value (USD Million) By Region

Table 14: Global Children Influenza Vaccine Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Children Influenza Vaccine Market Volume (K) By Region

Table 31: Global Children Influenza Vaccine Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Children Influenza Vaccine Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Children Influenza Vaccine Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Children Influenza Vaccine Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Sanofi Basic Information And Sales Area

Table 52: Sanofi. Products Portfolio

Table 53: CSL Basic Information And Sales Area

Table 54: CSL. Products Portfolio

Table 55: GSK Basic Information And Sales Area

Table 56: GSK. Products Portfolio

Table 57: Viatris Basic Information And Sales Area

Table 58: Viatris. Products Portfolio

Table 59: Hulan Bio Basic Information And Sales Area

Table 60: Hulan Bio. Products Portfolio

Table 61: AstraZeneca Basic Information And Sales Area

Table 62: AstraZeneca. Products Portfolio

Table 63: CCBIO Basic Information And Sales Area

Table 64: CCBIO. Products Portfolio

Table 65: Sinovac Basic Information And Sales Area

Table 66: Sinovac. Products Portfolio

Table 67: BCHT Basic Information And Sales Area

Table 68: BCHT. Products Portfolio

Table 69: Jiangsu GDK Basic Information And Sales Area

Table 70: Jiangsu GDK. Products Portfolio

Table 71: KM Biologics Basic Information And Sales Area

Table 72: KM Biologics. Products Portfolio

Table 73: Global Market Value (USD Million) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Value (USD Million) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Market Volume (K) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Volume (K) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Children Influenza Vaccine Market Value (USD Million) By Region

Table 82: Global Children Influenza Vaccine Market Share (%) By Region (2025-2032)

Table 83: North America Market Value (USD Million) (2025-2032) By Country

Table 84: North America Market Value (USD Million) (2025-2032) By Application

Table 85: North America Market Value (USD Million) (2025-2032) By Types

Table 86: Europe Market Value (USD Million) (2025-2032) By Country

Table 87: Europe Market Value (USD Million) (2025-2032) By Application

Table 88: Europe Market Value (USD Million) (2025-2032) By Types

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 92: South America Market Value (USD Million) (2025-2032) By Country

Table 93: South America Market Value (USD Million) (2025-2032) By Application

Table 94: South America Market Value (USD Million) (2025-2032) By Types

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 98: Global Children Influenza Vaccine Market Volume (K) By Region

Table 99: Global Children Influenza Vaccine Market Share (%) By Region (2025-2032)

Table 100: North America Market Volume (K) (2025-2032) By Country

Table 101: North America Market Volume (K) (2025-2032) By Application

Table 102: North America Market Volume (K) (2025-2032) By Types

Table 103: Europe Market Volume (K) (2025-2032) By Country

Table 104: Europe Market Volume (K) (2025-2032) By Application

Table 105: Europe Market Volume (K) (2025-2032) By Types

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 107: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 109: South America Market Volume (K) (2025-2032) By Country

Table 110: South America Market Volume (K) (2025-2032) By Application

Table 111: South America Market Volume (K) (2025-2032) By Types

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 113: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 115: Research Programs/Design For This Report

Table 116: Key Data Information From Secondary Sources

Table 117: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Children Influenza Vaccine Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	24.05 million
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sanofi; CSL; GSK; Viatris; Hulan Bio; AstraZeneca; CCBIO; Sinovac; BCHT; Jiangsu GDK; KM Biologics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Supply chain disruptions and manufacturing capacity constraints can limit the availability of children influenza vaccines, hindering the growth forecast of the Children Influenza Vaccine market.

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Children Influenza Vaccine Segmentation Breakdown6 items

Application

Public

Private

Types

Nasal Spray

Injection

Regional Insights

Loading chart…

Competitive Landscape

Sanofi: regional expansion

CSL: premium pricing

GSK: innovation pipeline

Viatris: OEM tie-ups

Hulan Bio: local manufacturing

AstraZeneca: vertical integration

Key Children Influenza Vaccine Companies11 items

Sanofi

CSL

GSK

Viatris

Hulan Bio

AstraZeneca

CCBIO

Sinovac

BCHT

Jiangsu GDK

KM Biologics

Market Ecosystem

Raw material suppliers — providing vaccine components

OEMs / manufacturers — producing influenza vaccines

Technology providers — developing vaccine technologies

Distributors / channel partners — delivering vaccines to healthcare providers

Service providers / after-sales — offering vaccination services and support

Regulators/standards bodies — overseeing vaccine safety and efficacy

End users / buyers — receiving and administering influenza vaccines

Recent Industry Insights

Analyst Overview

Table of Contents